The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.
about
Interventions for bronchiectasis: an overview of Cochrane systematic reviewsProlonged antibiotics for non-cystic fibrosis bronchiectasis in children and adultsYear in review 2014: Chronic obstructive pulmonary disease, asthma and airway biologyBronchiectasis in the Last Five Years: New DevelopmentsMatrix metalloproteinases vary with airway microbiota composition and lung function in non-cystic fibrosis bronchiectasisBronchiectasis and Aspergillus: How are they linked?Bronchiectasis in Children: Current Concepts in Immunology and MicrobiologyAscites bacterial burden and immune cell profile are associated with poor clinical outcomes in the absence of overt infection.Adult non-cystic fibrosis bronchiectasis is characterised by airway luminal Th17 pathway activation.Lung Microbiota Changes Associated with Chronic Pseudomonas aeruginosa Lung Infection and the Impact of Intravenous Colistimethate Sodium.Longitudinal assessment of sputum microbiome by sequencing of the 16S rRNA gene in non-cystic fibrosis bronchiectasis patients.Treatment with macrolides and glucocorticosteroids in severe community-acquired pneumonia: A post-hoc exploratory analysis of a randomized controlled trial.Challenges in the development of new therapies for bronchiectasis.Identification of novel chemotherapeutic strategies for metastatic uveal melanoma.Understanding persistent bacterial lung infections: clinical implications informed by the biology of the microbiota and biofilmsThe Evolving Cystic Fibrosis Microbiome: A Comparative Cohort Study Spanning 16 Years.The past decade in bench research into pulmonary infectious diseases: What do clinicians need to know?Macrolides protect against Pseudomonas aeruginosa infection via inhibition of inflammasomes.Gut microbiota and protection from pneumococcal pneumoniaThe European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC): experiences from a successful ERS Clinical Research Collaboration.A pediatric disease to keep in mind: diagnostic tools and management of bronchiectasis in pediatric age.Macrolides, inflammation and the lung microbiome: untangling the web of causality.[Pseudomonas aeruginosa infections in chronic obstructive pulmonary disease : Role of long-term antibiotic treatment].Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis.PPARγ is reduced in the airways of non-CF bronchiectasis subjects and is inversely correlated with the presence of Pseudomonas aeruginosa
P2860
Q24186645-9399C570-B650-4E1B-8E16-218EFF2D35E8Q24187890-BBDC01C8-6408-40AC-A52D-55ACA29246D5Q27024394-61961EAA-259D-45A4-A5EA-B83290394E2DQ28075732-26DF314B-98BD-420B-8574-67B8436EB6F4Q28256930-D865BD77-4BF9-4D82-9EE9-37519261CE34Q30243947-4A16EEFA-9EDE-45DE-96D4-495139A1B969Q33734772-24933CAC-046F-4288-BC1F-26CEBD80DDA0Q35189328-843F38DC-F269-4FF0-AA2F-5CE3F6A872D5Q35231255-0624F59F-AAE9-4361-9D81-6FBAFE40A123Q36257805-F1003637-18EE-47CF-92D7-5D29B839983BQ36272824-C07535DE-693E-4BCA-BF30-92A050311C98Q36406243-0F7061C7-3009-426E-A3C8-8F04C2229E13Q38387657-334AEA9D-FE85-4957-8C5B-2442251A7CE7Q38901800-19F7653F-0E61-46AC-B7FA-55F536858F2EQ39167799-3502F92A-8922-464F-A8B1-E8BAD0CAE705Q39328796-F0766E3D-5E03-4EEA-9A50-873C38F9879BQ39402027-543AE985-AEB6-4C5F-8857-0D7D3AC08D67Q40144933-93A57E48-E2A0-4618-A383-E7F4E089B399Q40731595-F373D274-B2E9-49CC-9CC4-31423A5DEDBAQ41615902-B96D0339-3701-4201-B021-889BD63E3230Q48335145-7CEBA760-9A14-4D33-B39C-10AC4CFD5573Q49448728-D10CFBB0-3E07-45A6-9855-EF772AD9FE37Q49567820-2B9F40DA-5236-4DF3-9BA0-6CBC2BE27653Q54965235-09381227-EC9A-4F24-B657-25000C41CA4BQ58775115-A8504657-0238-448C-84C3-415C2C4375FB
P2860
The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The effect of long-term macrol ...... lacebo-controlled BLESS trial.
@ast
The effect of long-term macrol ...... lacebo-controlled BLESS trial.
@en
type
label
The effect of long-term macrol ...... lacebo-controlled BLESS trial.
@ast
The effect of long-term macrol ...... lacebo-controlled BLESS trial.
@en
prefLabel
The effect of long-term macrol ...... lacebo-controlled BLESS trial.
@ast
The effect of long-term macrol ...... lacebo-controlled BLESS trial.
@en
P2093
P1476
The effect of long-term macrol ...... placebo-controlled BLESS trial
@en
P2093
David J Serisier
Kenneth D Bruce
Megan L Martin
P304
P356
10.1016/S2213-2600(14)70213-9
P577
2014-10-14T00:00:00Z